1049 related articles for article (PubMed ID: 25454613)
1. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.
Skolarikos A; Straub M; Knoll T; Sarica K; Seitz C; Petřík A; Türk C
Eur Urol; 2015 Apr; 67(4):750-63. PubMed ID: 25454613
[TBL] [Abstract][Full Text] [Related]
2. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
3. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
Hess B
Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Work-up of Patients with Urolithiasis: Indications and Diagnostic Algorithm.
Tiselius HG; Daudon M; Thomas K; Seitz C
Eur Urol Focus; 2017 Feb; 3(1):62-71. PubMed ID: 28720369
[TBL] [Abstract][Full Text] [Related]
5. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
[TBL] [Abstract][Full Text] [Related]
6. The most important metabolic risk factors in recurrent urinary stone formers.
Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
[TBL] [Abstract][Full Text] [Related]
7. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
Tefekli A; Esen T; Ziylan O; Erol B; Armagan A; Ander H; Akinci M
Urol Int; 2003; 70(4):273-7. PubMed ID: 12740490
[TBL] [Abstract][Full Text] [Related]
8. Metabolic abnormalities associated with calyceal diverticular stones.
Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and low urinary citrate excretion in calcium stone formers.
Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
[TBL] [Abstract][Full Text] [Related]
11. The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results.
Wu W; Yang D; Tiselius HG; Ou L; Liang Y; Zhu H; Li S; Zeng G
Urology; 2014 Apr; 83(4):732-7. PubMed ID: 24485999
[TBL] [Abstract][Full Text] [Related]
12. Urinary metabolic evaluations in solitary and recurrent stone forming children.
DeFoor W; Minevich E; Jackson E; Reddy P; Clark C; Sheldon C; Asplin J
J Urol; 2008 Jun; 179(6):2369-72. PubMed ID: 18433777
[TBL] [Abstract][Full Text] [Related]
13. [Mineralogical composition of urinary stones, risk factors and metabolic disturbances in patients with calcium-oxalate urolithiasis].
Kustov AV; Strelnikov AI; Moryganov MA; Airapetyan AO; Smirnov PR; Lyalyakina EV; Toms SR
Urologiia; 2017 Sep; (4):22-26. PubMed ID: 28952687
[TBL] [Abstract][Full Text] [Related]
14. Prevention of stone disease.
Porena M; Guiggi P; Micheli C
Urol Int; 2007; 79 Suppl 1():37-46. PubMed ID: 17726351
[TBL] [Abstract][Full Text] [Related]
15. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
16. Clinical and metabolic evaluation of Korean patients with urolithiasis.
Park KJ; Jeon SS; Han DH; Lee SY
Scand J Clin Lab Invest; 2011 Oct; 71(6):481-5. PubMed ID: 21714706
[TBL] [Abstract][Full Text] [Related]
17. Evaluation and treatment of pediatric idiopathic urolithiasis-revisited.
Alon US; Zimmerman H; Alon M
Pediatr Nephrol; 2004 May; 19(5):516-20. PubMed ID: 15015063
[TBL] [Abstract][Full Text] [Related]
18. Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithiasis.
Karagülle O; Smorag U; Candir F; Gundermann G; Jonas U; Becker AJ; Gehrke A; Gutenbrunner C
World J Urol; 2007 Jun; 25(3):315-23. PubMed ID: 17333204
[TBL] [Abstract][Full Text] [Related]
19. Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers.
Doizi S; Poindexter JR; Pearle MS; Blanco F; Moe OW; Sakhaee K; Maalouf NM
J Urol; 2018 Dec; 200(6):1278-1284. PubMed ID: 30036516
[TBL] [Abstract][Full Text] [Related]
20. Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial.
Soygür T; Akbay A; Küpeli S
J Endourol; 2002 Apr; 16(3):149-52. PubMed ID: 12028622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
